All vaccines used in the UK must be authorised by our independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). Each COVID-19 vaccine candidate is assessed by teams of scientists and clinicians on a case-by-case basis and is only authorised once it has met robust standards of effectiveness, safety and quality set by MHRA. The MHRA has reviewed the available safety and efficacy data supporting Moderna’s bivalent vaccine and provided its authorisation.
There are no results that match your search criteria